Cancer news

The latest news in cancer research, health and policy by Cancer Research UK.

We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy. 

Health Service Policy

Three new cancer treatments available for NHS patients in Scotland

A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland.

New skin cancer immunotherapy added to NHS England’s Cancer Drugs Fund

A new immunotherapy treatment for certain advanced skin cancer patients is to be made available on the NHS in England.

The first complete picture of how long it takes to diagnose cancer in England

Researchers have gathered the most complete picture of how long people wait for a cancer diagnosis in England. And there's huge variation between referrals.

NHS to ‘fast track’ new personalised cancer medicines – but it’s not ready quite yet

NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.

NICE U-turn opens up new treatment option for some adults with leukaemia

Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.

Kidney and lung cancer drugs approved on the NHS in Scotland

One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment.

Prostate cancer MRI scans: is the NHS ready?

All men with suspected prostate cancer should be offered a specialist MRI scan, before a biopsy. That's the new recommendation, but is the NHS ready?

Kidney cancer immunotherapy combo approved for NHS use in England

A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.

Linking cancer drug prices to treatment success could speed up approvals. But what do patients consider success?

With NHS budgets stretched, it’s critical that cancer drugs offer value for money. We’ve teamed up with the Greater Manchester Health and Social Care Partnership to...

Pages